These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 29343193

  • 1. Perinatal sclerostin concentrations in abnormal fetal growth: the impact of gestational diabetes.
    Briana DD, Boutsikou M, Marmarinos A, Gourgiotis D, Malamitsi-Puchner A.
    J Matern Fetal Neonatal Med; 2019 Jul; 32(13):2228-2232. PubMed ID: 29343193
    [Abstract] [Full Text] [Related]

  • 2. Differential expression of cord blood neurotrophins in gestational diabetes: the impact of fetal growth abnormalities.
    Briana DD, Papastavrou M, Boutsikou M, Marmarinos A, Gourgiotis D, Malamitsi-Puchner A.
    J Matern Fetal Neonatal Med; 2018 Feb; 31(3):278-283. PubMed ID: 28081639
    [Abstract] [Full Text] [Related]

  • 3. Implication of the myokine irisin in maternal energy homeostasis in pregnancies with abnormal fetal growth.
    Briana DD, Boutsikou M, Athanasopoulos N, Marmarinos A, Gourgiotis D, Malamitsi-Puchner A.
    J Matern Fetal Neonatal Med; 2016 Nov; 29(21):3429-33. PubMed ID: 26735968
    [Abstract] [Full Text] [Related]

  • 4. Cord blood survivin concentrations in human full-term normal and complicated pregnancies.
    Malamitsi-Puchner A, Baka S, Boutsikou M, Liosi S, Gourgiotis D, Protonotariou E, Hassiakos D, Briana DD.
    In Vivo; 2009 Nov; 23(1):139-42. PubMed ID: 19368138
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adropin concentrations in term pregnancies with normal, restricted and increased fetal growth.
    Baka S, Malamitsi-Puchner A, Briana DD, Boutsikou M, Marmarinos A, Gourgiotis D, Boutsikou T.
    J Matern Fetal Neonatal Med; 2016 Nov; 29(15):2403-7. PubMed ID: 26490387
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of intrauterine growth pattern on serum visfatin concentrations in full-term infants at birth and at 6 months of life.
    El Shemi MS, Mohamed MH, AbdelRahman AO, Abdel Al H, Ramadan NM.
    J Neonatal Perinatal Med; 2016 Nov; 9(1):73-82. PubMed ID: 27002258
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction.
    Briana DD, Boutsikou M, Baka S, Hassiakos D, Gourgiotis D, Malamitsi-Puchner A.
    Neonatology; 2009 Nov; 96(2):132-6. PubMed ID: 19365143
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of intrauterine growth on leukocyte telomere length at birth.
    Stefa A, Lamprokostopoulou A, Briana DD, Kontogeorgou A, Papageorgiou I, Malamitsi-Puchner A, Tsitsilonis O, Gagos S, Charmandari E.
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3948-3953. PubMed ID: 29779414
    [Abstract] [Full Text] [Related]

  • 15. Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus.
    Mazaki-Tovi S, Romero R, Vaisbuch E, Kusanovic JP, Chaiworapongsa T, Kim SK, Mittal P, Dong Z, Pacora P, Yeo L, Hassan SS.
    J Perinat Med; 2010 Mar; 38(2):147-55. PubMed ID: 20146659
    [Abstract] [Full Text] [Related]

  • 16. Delivery outcomes of large-for-gestational-age newborns stratified by the presence or absence of gestational diabetes mellitus.
    Rosen H, Shmueli A, Ashwal E, Hiersch L, Yogev Y, Aviram A.
    Int J Gynaecol Obstet; 2018 Apr; 141(1):120-125. PubMed ID: 29139556
    [Abstract] [Full Text] [Related]

  • 17. Cord blood galectin-1 and -3 concentrations in term pregnancies with normal restricted and increased fetal growth.
    Boutsikou T, Giotaki M, Boutsikou M, Briana DD, Baka S, Piatopoulou D, Hassiakos D, Gourgiotis D, Malamitsi-Puchner A.
    J Perinat Med; 2015 May; 43(3):305-9. PubMed ID: 24717333
    [Abstract] [Full Text] [Related]

  • 18. Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes.
    Lindsay RS, Westgate JA, Beattie J, Pattison NS, Gamble G, Mildenhall LF, Breier BH, Johnstone FD.
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):322-8. PubMed ID: 17302863
    [Abstract] [Full Text] [Related]

  • 19. Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight.
    Mazaki-Tovi S, Romero R, Kusanovic JP, Vaisbuch E, Erez O, Than NG, Chaiworapongsa T, Nhan-Chang CL, Pacora P, Gotsch F, Yeo L, Kim SK, Edwin SS, Hassan SS, Mittal P.
    J Perinat Med; 2009 Mar; 37(3):218-31. PubMed ID: 19099366
    [Abstract] [Full Text] [Related]

  • 20. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants.
    Akcakus M, Koklu E, Kurtoglu S, Kula M, Koklu SS.
    Am J Perinatol; 2006 Nov; 23(8):473-80. PubMed ID: 17094045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.